Jamie L. Reynoso - 14 Mar 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Signature
/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso
Issuer symbol
CLOV
Transactions as of
14 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 16:33:00 UTC
Previous filing
20 Jan 2026
Next filing
18 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reynoso Jamie L. CEO, Medicare Advantage C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso 17 Mar 2026 0001839066

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability -8,945 -0.33% $1.98* 2,728,755 14 Mar 2026 Direct F1
transaction CLOV Class A Common Stock Tax liability -6,187 -0.23% $1.98* 2,722,568 15 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022.
F2 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.